secwatch / observer
8-K filed January 15, 2025, 6:59 PM ET ticker SER CIK 0001708599
leadership confidence high sentiment neutral materiality 0.45

Serina Therapeutics appoints Karen J. Wilson to board; Steven Mintz departs

Serina Therapeutics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven Mintz

Director
SER · Serina Therapeutics, Inc.
Filed
January 15, 2025, 6:59 PM ET
departure of Steven Mintz from its Board of Directors
Appointed

Karen J. Wilson

Director
SER · Serina Therapeutics, Inc.
Effective
2025-01-14
Filed
January 15, 2025, 6:59 PM ET
appointment of Karen J. Wilson to the Company’s Board of Directors, effective January 14, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Mintz departed as Director at Serina Therapeutics, Inc..

Action
departed
Role
Director
Exact text from the filing
departure of Steven Mintz from its Board of Directors
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Karen J. Wilson was appointed as Director at Serina Therapeutics, Inc..

Action
appointed
Role
Director
Exact text from the filing
appointment of Karen J. Wilson to the Company’s Board of Directors, effective January 14, 2025
View on SEC.gov

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001708599-25-000005
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.